The downregulation of circ_0043256 suppresses the tumorigenic potential of GC cells by increasing the expression of miR-593-5p and decreasing the expression of ribonucleoside-diphosphate reductase subunit M2 (RRM2) to inhibit the glycolytic pathway [106]. Here, RRM2 is linked to gastric cancer.